- Home
- MINE vs LFCR Comparison
MINE vs LFCR Comparison
Compare MINE & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MINE | LFCR |
|---|---|---|
| Founded | 2019 | 1986 |
| Country | Canada | United States |
| Employees | 6 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.5M | 269.8M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | MINE | LFCR |
|---|---|---|
| Price | $3.38 | $4.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 39.8K | ★ 264.8K |
| Earning Date | 01-01-0001 | 06-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | $2.32 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.31 | $4.09 |
| 52 Week High | $4.45 | $8.98 |
Technical Indicators
Market Signals| Indicator | MINE | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 10.45 |
| Support Level | N/A | N/A |
| Resistance Level | $4.38 | $8.54 |
| Average True Range (ATR) | 0.25 | 0.49 |
| MACD | -0.06 | -0.28 |
| Stochastic Oscillator | 0.00 | 8.00 |
Price Performance
Historical ComparisonAbout MINE Mayfair Gold Corp. Common Shares
Mayfair Gold Corp is a mineral exploration company that is engaged in the acquisition and exploration of mineral properties. It has one material mineral property, the Fenn-Gib Gold Property, located in the Guibord, Munro, Michaud, and McCool Townships in northeast Ontario, which is in the exploration stage.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.